Jessica R Furst 1, Leonardo C Bandeira 1, Wen-Wei Fan 1, Sanchita Agarwal 1, Kyle K Nishiyama 1, Donald J McMahon 1, Elzbieta Dworakowski 1, Hongfeng Jiang 1, Shonni J Silverberg 1, Mishaela R Rubin 1 J Clin Endocrinol […]
J Bone Miner Res. 2014 Apr;29(4):787-95. doi: 10.1002/jbmr.2106. PMID: 24123088 PMCID: PMC3961509 DOI: 10.1002/jbmr.2106 Although patients with type 2 diabetes (T2D) are at significant risk
Pamela Rufus-Membere 1, Kara L Holloway-Kew 1, Adolfo Diez-Perez 2, Mark A Kotowicz 1 3 4, Julie A Pasco 1 3 4 Endocrinology. 2019 Sep 1;160(9):2143-2150. doi: 10.1210/en.2019-00415. PMID: 31310275 DOI: 10.1210/en.2019-00415 Impact microindentation (IMI) measures bone
Kristin L Popp 1, Signe Caksa 2, Adriana Martinez-Betancourt 2, Amy Yuan 2, Joy Tsai 1, Elaine W Yu 1, Mary L Bouxsein 1 3 J Bone Miner Res. 2019 Jan;34(1):75-82. doi: 10.1002/jbmr.3590. Epub 2018 Nov 5.
Lisa Johansson 1 2, Daniel Sundh 1, Michael Zoulakis 1, Robert Rudäng 1, Anna Darelid 1, Helena Brisby 2 3, Anna G Nilsson 1, Dan Mellström 1 4, Mattias Lorentzon 1 4 J Bone Miner Res. 2018 Feb;33(2):250-260. doi: 10.1002/jbmr.3297. Epub 2017 Nov 15.
Tamara D Rozental 1 2, Kempland C Walley 1, Serkalem Demissie 3, Signe Caksa 4, Adriana Martinez-Betancourt 4, Amber M Parker 1, Joy N Tsai 4 5, Elaine W Yu 4 5, Mary L Bouxsein 1 2 4 J Bone Miner Res. 2018
Daysi Duarte Sosa 1, Erik Fink Eriksen 2 Calcif Tissue Int. 2017 Jul;101(1):34-42. doi: 10.1007/s00223-017-0256-5. Epub 2017 Feb 28. PMID: 28246929 DOI: 10.1007/s00223-017-0256-5 The aim of the study
Xavier Nogués 1, Daniel Prieto-Alhambra 2, Roberto Güerri-Fernández 1, Natalia Garcia-Giralt 3, Jaime Rodriguez-Morera 1, Lourdes Cos 1, Leonardo Mellibovsky 1, Adolfo Díez Pérez 4 Bone. 2017 Oct;103:64-69. doi: 10.1016/j.bone.2017.06.018. Epub 2017 Jun 24. PMID: 28655603 DOI: 10.1016/j.bone.2017.06.018 Background: Some
F Malgo 1, N A T Hamdy 1, S E Papapoulos 1, N M Appelman-Dijkstra 2 Osteoporos Int. 2017 Aug;28(8):2433-2437. doi: 10.1007/s00198-017-4054-8. Epub 2017 May 2. PMID: 28466137 PMCID: PMC5524858 DOI: 10.1007/s00198-017-4054-8 We
R Rudäng 1, M Zoulakis 1, D Sundh 1, H Brisby 2, A Diez-Perez 3, L Johansson 1, D Mellström 1, A Darelid 1, M Lorentzon 4 Osteoporos Int. 2016 Apr;27(4):1585-1592. doi: 10.1007/s00198-015-3419-0. Epub 2015 Dec 2. PMID: 26630975 PMCID: PMC4791463 DOI: 10.1007/s00198-015-3419-0
Indication For Use and Safety Information
The OsteoProbe is indicated for use as a measurement tool to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. The device is not intended to diagnose or treat any clinical condition.
Like with any percutaneous procedure, there is a small risk of infection. The sale, distribution, and use of the OsteoProbe are restricted to prescription use. Federal law (United States of America) restricts this device to use by, or on the order of, a physician.
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy